• Premier Health (PHA) announced a 245-per-cent-increase in revenue for the second quarter of 2021
  • The company filed its condensed interim consolidated financial statements
  • The company generated revenues of $17.0 million for the quarter
  • The company attributes the increase to its full consolidation of the Code Bleu acquisition and organic growth
  • Premier Health is up 2.21 per cent, trading at $1.39 at 2:48 pm ET

Premier Health (PHA) announced a 245-per-cent-increase in revenue for the second quarter of 2021.

The Canadian healthtech company filed its condensed interim consolidated financial statements.

The company generated revenues of $17.0 million for the quarter ($30.4 million for the 6-month period compared to $8.2 million for the same period in 2020).

The company attributes the increase to its full consolidation of the Code Bleu acquisition and organic growth.

“The March offering and the latest technology roll out puts us in a very enviable position to act as an aggregator in our market,” said Premier Health CEO Martin Legault.

Premier Health is a leading Canadian Healthtech company that provides a comprehensive range of outsourced services solutions for healthcare needs to governments, corporations, and individuals.

Premier Health is up 2.21 per cent, trading at $1.39 at 2:48 pm ET.

More From The Market Online

Reliq Health expands contract with U.S. health group

Reliq Health Technologies (TSXV:RHT) reveals it has expanded an existing contract with a large U.S. health group.

Telo Genomics and Emery Pharma collaborate

Telo Genomics (TSXV:TELO) collaborates with Emery Pharma to enhance cellular and molecular bioanalytical solutions for clinical research.

UniDoc brings AI to ER patients

UniDoc (CSE:UDOC) expands its AI partnership with DocBox, further integrating predictive analytics into emergency room operations.